Close X
Monday, December 2, 2024
ADVT 
International

Students from UP in Ukraine want to be vacated

Darpan News Desk IANS, 17 Feb, 2022 03:14 PM
  • Students from UP in Ukraine want to be vacated

Bareilly/Rampur (Uttar Pradesh), Feb 17 (IANS) Around 20 medical students from Bareilly and Rampur district are stuck in Ukraine, following border tension with Russia. They want the government of India to evacuate them, according to family members.

There are currently around 50 students from Bareilly studying in Ukraine.

Subhan Ahmed from Rampur is pursuing his studies in medicine in Ukraine. His family belongs to Kheda Tanda under Azimnagar police station.

Subhan's father, Jalees Ahmad, said, "My son is studying MBBS from National University in Uzhhorod. The students there have been asked to stay indoors. Flight services are demanding a much higher fare, which is difficult for us to afford. We had a word with Subhan over the phone."

The students mainly belong to Bithri Chainpur, Bareilly, Bahedi, Fatehganj West and Rampur.

Another student, Harsh's parent said that he had told them that he was in touch with the Indian embassy there.

Ukrainian colleges, hosts a large number of Indian students who are studying medicine and also enrolled in other courses.

Families of the students have also appealed to the government of India and asked their children to be airlifted if the situation on the ground changes in Ukraine.

The Indian Embassy in Kyiv had urged the Indian students, on Tuesday, to 'temporarily leave the capital city'. It also urged citizens whose stay in Ukraine is non-essential, to leave the country.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK